Viridian Therapeutics (NASDAQ:VRDN – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a report released on Monday,Benzinga reports. They presently have a $32.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 78.77% from the stock’s […]

Medtronic (NYSE:MDT – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports. They currently have a $101.00 target price on the medical technology company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 24.14% from the […]

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $102.00 price objective on the biopharmaceutical company’s stock. Needham & Company LLC’s price objective would indicate a potential upside of 35.62% from the […]